CClinicalTrials.gg
Not yet recruitingNCT06641492Updated Oct 15, 2024

A RCT Evaluating a Chatbot in Increasing Physical Activity Among Older Adults

An interventional study of Chatbot-delivered interventions tailored to one's stage of changes and Chatbot-delivered standard interventions in Physical Inactivity, sponsored by Chinese University of Hong Kong. Not yet recruiting at 1 site in Hong Kong. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-10-15.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
278
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

This study will compare the efficacy of a Chatbot-delivered stage of changes (SOC)-tailored online intervention (intervention group) versus a Chatbot-delivered non-SOC-tailored online intervention in increasing the prevalence of meeting WHO recommended physical activity level six months after completion of the intervention among inactive community-dwelling individuals aged ≥65 yeas. In the intervention group, the Chatbot will assess participants' physical activity level and SOC regarding PA and automatically deliver interventions tailor to their SOC every week for 12 weeks. In the control group, the Chatbot will not assess participants' SOC. It will assess participants' physical activity level and provides a standard intervention covering general information about physical activity for older adults, which is not tailoring to participants'SOC every week for 12 weeks. All participants will be followed up after completion of the interventions (T1) and six months after T1 (T2).

02

Conditions studied

  • Physical Inactivity
03

In context

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged ≥65 years,
  • Having a Hong Kong ID,
  • Chinese speaking,
  • Not meet the WHO recommended level of MVPA
  • Willing to be followed by telephone at 3 and 9 months,
  • Having a smartphone
  • Able to send and read text/voice message via smartphone.
  • Willing to wear an accelerometer for a week at T0, T1 and T2.

Exclusion criteria

Exclusion Criteria:

  • Blindness or deafness,
  • Having been diagnosed with major psychiatric illness (schizophrenia or bipolar disorder) or dementia,
  • Score ≥1 in the Chinese version of the Physical Activity Readiness Questionnaire (PAR-Q)
  • Score ≤16 in the validated telephone version of the Cantonese Mini-mental State Examination (T-CMMSE)
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
278 participants (estimated)

Study arms

  • Experimental
    Intervention

    The Chatbot will assess participants' physical activity level and stage of changes regarding physical activity and automatically deliver interventions tailor to their stage of changes every week for 12 weeks. The Chatbot will address questions related to physical activity raised by the participants.

    Behavioral: Chatbot-delivered interventions tailored to one's stage of changes

  • Active comparator
    Control

    The Chatbot will not assess participants' stage of changes. It will assess participants' physical activity level and provides a standard intervention covering general information about physical activity for older adults, which is not tailoring to participants' stage of changes every week for 12 weeks. The Chatbot will address questions related to physical activity raised by the participants.

    Behavioral: Chatbot-delivered standard interventions

Interventions

  • BehavioralChatbot-delivered interventions tailored to one's stage of changes

    The Chatbot will assess participants' physical activity level and stage of changes regarding physical activity and automatically deliver interventions tailor to their stage of changes every week for 12 weeks. The Chatbot will address questions related to physical activity raised by the participants.

  • BehavioralChatbot-delivered standard interventions

    The Chatbot will not assess participants' stage of changes. It will assess participants' physical activity level and provides a standard intervention covering general information about physical activity for older adults, which is not tailoring to participants' stage of changes every week for 12 weeks. The Chatbot will address questions related to physical activity raised by the participants.

06

What researchers measure

Primary outcomes

  1. Meeting WHO recommended level of physical activity

    Prevalence of meeting WHO recommended level of physical activity (at least 150 minutes moderate-intensity aerobic physical activity every week) at T1 (after completion of intervention) and T2 (6 months after T1). Physical activity will be measured by self-reported data and using an accelerometer.

    Time frame: 9 months

07

Study locations

1 site
  • Centre for Health Behaviours Research, the Chinese University of Hong Kong
    Hong Kong, 666888, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06641492
Lead sponsor
Chinese University of Hong Kong
Responsible party
Zixin Wang (Assistant Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Oct 15, 2024
Start date
Nov 1, 2024 (estimated)
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Oct 15, 2024

Study contacts

Zixin Wang, Dr.
Contact
wangzx@cuhk.edu.hk
+852 22528740
Zixin Wang, Dr.
principal investigator · Centre for Health Behaviours Research, the Chinese University of Hong Kong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion